Table 2

Response to maintenance Bevacizumab (mBev) according to activity of Bevacizumab plus Paclitaxel (BT)
Response mBev
Activity BT CR PR SD PD
n n(%) n(%) n(%) n(%)
4 CR 4 (100)
18 PR 12 (66.7) 6 (33.3)
13 SD 1 (7.7) 10 (76.9) 2 (15.4)

mBev, maintenance Bevacizumab; CR, complete response; PR, partial response; SD, stable disease; PD, progression disease.

Fabi et al.

Fabi et al. BMC Cancer 2012 12:482   doi:10.1186/1471-2407-12-482

Open Data